Orla McNally

Whole–genome characterization of chemoresistant ovarian cancer

Ann‐Marie Patch, Elizabeth L. Christie, Dariush Etemadmoghadam et al. · Nature · 2015 · 1.6K citations

Medicine, Genetics, Oncology +14

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 306 citations · Full text

Medicine, Oncology, Surgery +13

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer

Kathleen M. Schmeler, René Pareja, Aldo López Blanco et al. · International Journal of Gynecological Cancer · 2021 · 230 citations · Full text

Medicine, Oncology, Surgery +17

The molecular origin and taxonomy of mucinous ovarian carcinoma

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland et al. · Nature Communications · 2019 · 187 citations · Full text

Medicine, Molecular Genetics, Oncology +17